These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28503555)

  • 21. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
    Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
    Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.
    Lang H; Sotiropoulos GC; Frühauf NR; Dömland M; Paul A; Kind EM; Malagó M; Broelsch CE
    Ann Surg; 2005 Jan; 241(1):134-43. PubMed ID: 15622001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent Intrahepatic Cholangiocarcinoma - Review.
    Bekki Y; Von Ahrens D; Takahashi H; Schwartz M; Gunasekaran G
    Front Oncol; 2021; 11():776863. PubMed ID: 34746017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature.
    Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K
    World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.
    Okabayashi T; Yamamoto J; Kosuge T; Shimada K; Yamasaki S; Takayama T; Makuuchi M
    Cancer; 2001 Nov; 92(9):2374-83. PubMed ID: 11745293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis.
    Spolverato G; Bagante F; Tsilimigras D; Ejaz A; Cloyd J; Pawlik TM
    J Surg Oncol; 2019 Mar; 119(3):278-287. PubMed ID: 30554420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival after surgical resection for recurrent hepatic and pulmonary metastases of intrahepatic cholangiocarcinoma: a case report.
    Yamada M; Arimoto A; Toyoda Y; Watanabe S; Aizu K; Sato F; Fujieda A; Yamaguchi R
    Surg Case Rep; 2019 Aug; 5(1):135. PubMed ID: 31432273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
    Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
    Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.
    Lei Z; Xia Y; Si A; Wang K; Li J; Yan Z; Yang T; Wu D; Wan X; Zhou W; Liu J; Wang H; Cong W; Wu M; Pawlik TM; Lau WY; Shen F
    J Hepatol; 2018 Apr; 68(4):655-662. PubMed ID: 29155069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients.
    Feng J; Liang B; Zhang HY; Liu Z; Jiang K; Zhao XQ
    World J Gastrointest Surg; 2022 May; 14(5):442-451. PubMed ID: 35734620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges of surgical management of intrahepatic cholangiocarcinoma.
    Squires MH; Cloyd JM; Dillhoff M; Schmidt C; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):671-681. PubMed ID: 29911912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution.
    Kim DH; Choi DW; Choi SH; Heo JS; Kow AW
    Surgery; 2015 Apr; 157(4):666-75. PubMed ID: 25682172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparison of current guidelines for the management of intrahepatic cholangiocarcinoma worldwide].
    Yu YX; Wu ZJ; Tang W; Liao R
    Zhonghua Wai Ke Za Zhi; 2023 Feb; 61(4):297-304. PubMed ID: 36822586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management.
    Zhang H; Yang T; Wu M; Shen F
    Cancer Lett; 2016 Sep; 379(2):198-205. PubMed ID: 26409434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: A multi-institutional study by the Kyushu Study Group of Liver Surgery.
    Yamashita YI; Shirabe K; Beppu T; Eguchi S; Nanashima A; Ohta M; Ueno S; Kondo K; Kitahara K; Shiraishi M; Takami Y; Noritomi T; Okamoto K; Ogura Y; Baba H; Fujioka H
    Ann Gastroenterol Surg; 2017 Jun; 1(2):136-142. PubMed ID: 29863136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
    Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
    Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.